These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 3978537)
1. A comparison of the actual and expected pain response following insertion of an intrauterine contraceptive device. Goldstuck ND; Matthews ML Clin Reprod Fertil; 1985 Mar; 3(1):65-71. PubMed ID: 3978537 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the actual and expected response following removal of an IUD. Goldstuck ND; Matthews ML Adv Contracept Deliv Syst; 1985; (1):122-5. PubMed ID: 12267107 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the initial pain response following insertion of the Copper 7 and combined Multiload Copper 250-short IUDs. Goldstuck ND Contracept Deliv Syst; 1981 Oct; 2(4):295-301. PubMed ID: 12336990 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil. Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606 [TBL] [Abstract][Full Text] [Related]
5. [Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion]. Jensen HH; Blaabjerg J; Lyndrup J Ugeskr Laeger; 1998 Nov; 160(48):6958-61. PubMed ID: 9846090 [TBL] [Abstract][Full Text] [Related]
6. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women. Goldstuck ND Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989 [TBL] [Abstract][Full Text] [Related]
7. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Sääv I; Aronsson A; Marions L; Stephansson O; Gemzell-Danielsson K Hum Reprod; 2007 Oct; 22(10):2647-52. PubMed ID: 17652452 [TBL] [Abstract][Full Text] [Related]
8. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability]. Custo GM; Cosmi EV Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352 [TBL] [Abstract][Full Text] [Related]
18. Specific serum protein levels in women using intrauterine contraceptive device. Wiedermann D; Kríz J; Cídl K Czech Med; 1980; 3(3):239-47. PubMed ID: 6969168 [TBL] [Abstract][Full Text] [Related]
19. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Hubacher D; Reyes V; Lillo S; Zepeda A; Chen PL; Croxatto H Am J Obstet Gynecol; 2006 Nov; 195(5):1272-7. PubMed ID: 17074548 [TBL] [Abstract][Full Text] [Related]
20. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Edelman AB; Schaefer E; Olson A; Van Houten L; Bednarek P; Leclair C; Jensen JT Contraception; 2011 Sep; 84(3):234-9. PubMed ID: 21843686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]